Study: NCT03470259

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV adminstration of EMI-137
Description: Intravenous administration of the fluorescent tracer EMI-137 approximately two hours before incision. Thereafter will be an observational period of an hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV adminstration of EMI-137
Description: Intravenous administration of the fluorescent tracer EMI-137 approximately two hours before incision. Thereafter will be an observational period of an hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV adminstration of EMI-137
Description: Intravenous administration of the fluorescent tracer EMI-137 approximately two hours before incision. Thereafter will be an observational period of an hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV adminstration of EMI-137
Description: Intravenous administration of the fluorescent tracer EMI-137 approximately two hours before incision. Thereafter will be an observational period of an hour.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multispectral Fluorescence Reflectance Imaging
Description: A multispectral Near Infrared Fluorescence (NIRF) camera system sensitive for EMI-137 fluorescence will be used for only ex-vivo Multispectral Fluorescence Reflectance Imaging (MFRI) of the thyroid gland and/or lymph node compartment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multispectral Fluorescence Reflectance Imaging
Description: A multispectral Near Infrared Fluorescence (NIRF) camera system sensitive for EMI-137 fluorescence will be used for only ex-vivo Multispectral Fluorescence Reflectance Imaging (MFRI) of the thyroid gland and/or lymph node compartment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multispectral Fluorescence Reflectance Imaging
Description: A multispectral Near Infrared Fluorescence (NIRF) camera system sensitive for EMI-137 fluorescence will be used for only ex-vivo Multispectral Fluorescence Reflectance Imaging (MFRI) of the thyroid gland and/or lymph node compartment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multispectral Fluorescence Reflectance Imaging
Description: A multispectral Near Infrared Fluorescence (NIRF) camera system sensitive for EMI-137 fluorescence will be used for only ex-vivo Multispectral Fluorescence Reflectance Imaging (MFRI) of the thyroid gland and/or lymph node compartment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spectroscopy
Description: A spectroscopy system sensitive for EMI-137 fluorescence will be used for only ex-vivo spectroscopy of the thyroid gland and/or lymph node compartment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spectroscopy
Description: A spectroscopy system sensitive for EMI-137 fluorescence will be used for only ex-vivo spectroscopy of the thyroid gland and/or lymph node compartment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spectroscopy
Description: A spectroscopy system sensitive for EMI-137 fluorescence will be used for only ex-vivo spectroscopy of the thyroid gland and/or lymph node compartment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spectroscopy
Description: A spectroscopy system sensitive for EMI-137 fluorescence will be used for only ex-vivo spectroscopy of the thyroid gland and/or lymph node compartment.